[go: up one dir, main page]

AU2000272858A1 - Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments - Google Patents

Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments

Info

Publication number
AU2000272858A1
AU2000272858A1 AU2000272858A AU7285800A AU2000272858A1 AU 2000272858 A1 AU2000272858 A1 AU 2000272858A1 AU 2000272858 A AU2000272858 A AU 2000272858A AU 7285800 A AU7285800 A AU 7285800A AU 2000272858 A1 AU2000272858 A1 AU 2000272858A1
Authority
AU
Australia
Prior art keywords
hyperhomocysteinaemia
medicaments
treating
caused
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000272858A
Other languages
English (en)
Inventor
Jutta Dierkes
Klaus Luley
Sabine Westphal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2000272858A1 publication Critical patent/AU2000272858A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415Pyridoxine, i.e. Vitamin B6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2000272858A 2000-02-03 2000-09-08 Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments Abandoned AU2000272858A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10004651 2000-02-03
DE10004651A DE10004651A1 (de) 2000-02-03 2000-02-03 Kombination von blutdrucksenkenden Wirkstoffen mit Wirkstoffen, die den Homocysteinspiegel zu senken vermögen
PCT/EP2000/008801 WO2001056609A1 (fr) 2000-02-03 2000-09-08 Composition pharmaceutique destinee au traitement d'une hyperhomocysteinemie provoquee par un medicament

Publications (1)

Publication Number Publication Date
AU2000272858A1 true AU2000272858A1 (en) 2001-08-14

Family

ID=7629642

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000272858A Abandoned AU2000272858A1 (en) 2000-02-03 2000-09-08 Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments

Country Status (3)

Country Link
AU (1) AU2000272858A1 (fr)
DE (1) DE10004651A1 (fr)
WO (1) WO2001056609A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
WO2003045359A2 (fr) * 2001-11-26 2003-06-05 Astion Oncology Aps Combinaison de derives de cimetidine et de cysteine pour traiter le cancer
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
EG24716A (en) 2002-05-17 2010-06-07 Novartis Ag Combination of organic compounds
CA2534660A1 (fr) * 2003-08-05 2005-02-10 Galephar M/F Composition pharmaceutique a unite simple comprenant un melange de fibranne et un agent reducteur d'homocysteine
IL157397A (en) * 2003-08-14 2013-03-24 Dpharm Ltd Compounds, pharmaceutical compositions comprising same and uses thereof for the preparation of a medicament for the treatment of epilepsy
ITRM20030442A1 (it) * 2003-09-26 2005-03-27 Medosan Ind Biochimiche Riuni Te S R L Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.
AU2005262228A1 (en) * 2004-07-09 2006-01-19 Medicure International Inc. Combination therapies employing nicotinic acid derivatives or fibric acid derivatives
WO2006050581A2 (fr) 2004-11-10 2006-05-18 Jallal Messadek Betaine en tant qu'agent de lutte contre des maladies transmises par des arthropodes ou des moustiques
EP1681055A1 (fr) * 2005-01-13 2006-07-19 PEJO Iserlohn Heilmittel-und Diät-GmbH & Co.KG Préparation pharmaceutique pour le traitement des taux d'homocysteine elevés
WO2006086856A1 (fr) 2005-02-15 2006-08-24 Messadek, Jallal Compositions therapeutiques combinees et leurs procedes d’utilisation
CA2650556A1 (fr) 2005-04-27 2006-11-02 Jallal Messadek Combinaisons insuliniques
CN100497337C (zh) * 2006-11-20 2009-06-10 淮北辉克药业有限公司 叶酸二甲双胍及其制备方法
CN103386130A (zh) * 2013-06-27 2013-11-13 深圳奥萨医药有限公司 Ace抑制剂/噻嗪类利尿剂/5-甲基四氢叶酸药物组合物及用途
US10016379B2 (en) 2015-10-30 2018-07-10 Robin L. Webb Method of treatment for third spacing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008221A (en) * 1996-11-06 1999-12-28 Bristol-Myers Squibb Company Method for treating Alzheimer's disease with folic acid
WO1999044563A2 (fr) * 1998-03-06 1999-09-10 Brown Charles L Iii Composition pour le traitement et la prevention de coronaropathie

Also Published As

Publication number Publication date
WO2001056609A1 (fr) 2001-08-09
DE10004651A1 (de) 2001-08-16

Similar Documents

Publication Publication Date Title
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
AU781269C (en) Pharmaceutical compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2001271037A1 (en) Pharmaceutical compositions containing dds compounds
AU2001266338A1 (en) Pharmaceutical compositions for angiogenic therapy
AU2002302147A1 (en) Pharmaceutical composition
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
AU2001290239A1 (en) Medicinal composition
AU2002221115A1 (en) Medicinal compositions having improved absorbability
HUP0401612A3 (en) Pharmaceutical composition suitable for treating diabetes
AU2001273919A1 (en) Pharmaceutical compositions
AU2002215114A1 (en) Pharmaceutical compositions for inhalation
AU3945501A (en) Apparatus for dosage of medicaments
AU2002306687A1 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
AU4085201A (en) Pharmaceutical composition
AU3586401A (en) Pharmaceutical composition
AU2001292578A1 (en) Pharmaceutical compounds
AU2882699A (en) Stabilizing composition for pharmaceutical dosage forms
AU2001278705A1 (en) Pharmaceutical composition
AU2002331279A1 (en) Pharmaceutical composition for treating hypercholesterolaemia
HU9902296D0 (en) Pharmaceutical composition for treating caltification
AU4698900A (en) Pharmaceutical compositions for treating malaria
AUPR529701A0 (en) Pharmaceutical composition
AU2003252701A1 (en) Medicinal composition for treating thrombopenia